怀孕期间非常严重的肝脏内胆固醇形成,由阿扎西奥普林剂量导致
Lyra Meehan1, Daniel Saitta2, Natasha Frawley3
1Women's and Children's, Grampians Health, Ballarat, Victoria, Australia lyra.meehan@gmail.com.
BMJ case reports
|February 11, 2026
概括
非常严重的妊娠肝内胆固醇症 (ICP) 可以增加死产的风险. 这项案例研究表明,停止阿扎西奥普林,一种 thiopurine,迅速降低胆酸水平,在一个怀孕的患者与ICP.
科学领域:
- 肝病学 肝病学是一种肝病学.
- 产科 产科 产科 产科 产科
- 药理学 药理学是指药理学的学科.
背景情况:
- 非常严重的妊娠肝内胆固醇症 (ICP),定义为血清胆酸总量 (TSBA) >100μmol/L,与3.4%的死产风险有关.
- 提奥普林药物可能会增加孕妇患ICP的风险.
研究的目的:
- 在孕妇使用阿扎西奥普林治疗炎症性肠病时报告严重的ICP病例.
- 调查阿扎西奥普林停止对患有ICP的患者TSBA水平的影响.
主要方法:
- 一个怀孕27周的初怀孕患者出现和黄,诊断出非常严重的ICP (TSBA=117μmol/L).
- 该患者每天接受阿扎西奥普林200毫克的炎症性肠道疾病治疗;监测了提奥普林代谢物比率.
- 停止了阿扎西奥普林,并监测TSBA水平的变化.
主要成果:
- 停用阿扎西奥普林导致TSBA水平在7天内显著降低至31μmol/L.
- 提奥普林代谢物比率 (6MMP:TGN) 在怀孕12周时为34,怀孕27周时为21.
结论:
- 这一案例强调了怀孕期间使用蒂奥普林的潜在风险,特别是阿扎西奥普林.
- 建议在ICP开始时立即停止使用阿扎西奥普林,以防止TSBA水平进一步升高并减轻风险.
相关概念视频
Binet's Contribution to Measures of Intelligence
1.8K
Alfred Binet, along with his student Théophile Simon, was tasked by the French Ministry of Education in 1904 to create a method for identifying students who struggled to learn through conventional classroom instruction. This initiative aimed to address overcrowding by placing such students in specialized schools. Binet and Simon developed an intelligence test comprising 30 tasks, ranging from simple commands, like touching one's nose or ear, to more complex tasks, such as drawing...
1.8K
Wechsler's Contribution to Measures of Intelligence
2.1K
David Wechsler, a psychologist who worked with World War I veterans, developed a significant IQ test in 1939 called the Wechsler-Bellevue Intelligence Scale. This test was innovative because it combined several subtests that measured both verbal and nonverbal skills, reflecting Wechsler's belief that intelligence is a global capacity involving purposeful action, rational thinking, and effective interaction with the environment. This test later evolved into the Wechsler Adult Intelligence...
2.1K
Dose Size and Dosing Frequency: Determination Methods
328
Determining the optimal dose size and dosing frequency in pharmacotherapy is crucial for achieving therapeutic effectiveness while minimizing adverse effects. This article explores the methodologies employed in determining these parameters, focusing on their significance and interplay to tailor dosing regimens.Dose Size: Dose size refers to the amount of a drug administered in a single dose. It is determined based on the drug's pharmacodynamics and pharmacokinetics properties and...
328
Determination of Multiple Dosing Parameters: Loading and Maintenance Doses
250
A loading dose is an essential pharmacological strategy to rapidly achieve the target plasma drug concentration necessary for an immediate therapeutic effect. This approach is especially critical for drugs characterized by slow absorption or extended half-lives, where delaying therapeutic plasma levels could compromise treatment outcomes. By administering a loading dose, clinicians ensure a prompt onset of drug action, even for agents with complex pharmacokinetic profiles.Achieving steady-state...
250
Rational Dosage Regimen: Maintenance Dose and Loading Dose
5.6K
A rational dosage regimen considers a drug's pharmacokinetics, including its absorption, distribution, metabolism, and elimination from the body. By understanding these factors, the appropriate dosage can be determined, and the dosing schedule can be designed to achieve and maintain the desired therapeutic effect while minimizing adverse effects.
In most cases, drugs are administered repetitively or infused continuously to maintain a steady-state concentration in the body. At a steady...
In most cases, drugs are administered repetitively or infused continuously to maintain a steady-state concentration in the body. At a steady...
5.6K
Drug Dosing: Infants and Children
324
Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
324


